RABIPUR

This brand name is authorized in Austria, Spain, France, Croatia, Japan, Malta, Netherlands, New Zealand, Poland, Singapore, Tunisia, United Kingdom

Active ingredients

The drug RABIPUR contains one active pharmaceutical ingredient (API):

1 Rabies vaccine UNII I0V66KI1LD - RABIES VIRUS

Read about Rabies vaccine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RABIPUR Powder and solvent for solution for injection	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J07BG01	Rabies, inactivated, whole virus	J Antiinfectives for systemic use → J07 Vaccines → J07B Viral vaccines → J07BG Rabies vaccines
Discover more medicines within J07BG01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 80926
Country: FR	Base de données publique des médicaments	Identifier(s): 66800338
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 341977
Country: JP	医薬品医療機器総合機構	Identifier(s): 6313400E1025
Country: MT	Medicines Authority	Identifier(s): AA770/09201
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 95796
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16280
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100057149, 100349834
Country: SG	Health Sciences Authority	Identifier(s): 13202P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 1363011H